Lionel R Milgrom
Affiliation: Imperial College
- Entanglement, knowledge, and their possible effects on the outcomes of blinded trials of homeopathic provingsLionel R Milgrom
Department of Chemistry, Imperial College of Science, Technology and Medicine, South Kensington, London SW7 2AZ, United Kingdom
J Altern Complement Med 12:271-9. 2006..It is proposed here that such entanglement between remedy and placebo during these double-blind placebo controlled provings is the direct result of the blinding process...
- Toward a unified theory of homeopathy and conventional medicineLionel R Milgrom
Department of Chemistry, Imperial College London, South Kensington, United Kingdom
J Altern Complement Med 13:759-69. 2007..or internal biochemical imbalances as disease causes. Treatment is geared to eradicating causative factors, sometimes at the expense of the homeostatic immune system...
- Are randomized controlled trials (RCTs) redundant for testing the efficacy of homeopathy? A critique of RCT methodology based on entanglement theoryLionel R Milgrom
Department of Chemistry, Imperial College of Science, Technology and Medicine, London, United Kingdom
J Altern Complement Med 11:831-8. 2005..Reported here is a theoretical investigation of the consequences arising from this assumption proving to be false...
- Is homeopathy possible?Lionel R Milgrom
Department of Chemistry, Imperial College of Science, Technology and Medicine, South Kensington, Exhibition Road, London SW7 2AZ, UK
J R Soc Promot Health 126:211-8. 2006..While awaiting experimental evidence of these hypotheses, it is suggested that observations of clinical outcomes would be superior to RCTs for further testing homeopathy's efficacy...
- Patient-Practitioner-Remedy (PPR) entanglement, Part 8: 'Laser-like' action of the homeopathic therapeutic encounter as predicted by a gyroscopic metaphor for the vital forceLionel R Milgrom
Department of Chemistry, Imperial College of Science, Technology and Medicine, London, Great Britain
Forsch Komplementarmed Klass Naturheilkd 12:206-13. 2005....
- Treating Leick with like: response to criticisms of the use of entanglement to illustrate homeopathyLionel R Milgrom
Homeopathy Research Institute, 63 Vale Road, London N4 1PP, UK
Homeopathy 97:96-9. 2008..The authors have used accepted interpretations of quantum theory: Leick's view is coloured by skepticism concerning homeopathy...
- A new geometrical description of entanglement and the curative homeopathic processLionel R Milgrom
Homeopathy Research Institute, London, United Kingdom
J Altern Complement Med 14:329-39. 2008..One of these envisages "quantum macro-entanglement" among patient, practitioner, and remedy to form a "PPR" entangled state, from which the possibility of cure may manifest...
- A homeopath's response to unjust skepticismLionel R Milgrom
J Altern Complement Med 13:186-9. 2007
- "Torque-like" action of remedies and diseases on the vital force and their consequences for homeopathic treatmentLionel R Milgrom
Department of Chemistry, Imperial College London, London, UK
J Altern Complement Med 12:915-29. 2006..So far, this approach has illustrated the biphasal action of remedies, resonance phenomena arising out of homeopathic provings, and aspects of the therapeutic encounter...
- Towards a new model of the homeopathic process based on quantum field theoryLionel R Milgrom
Department of Chemistry, Imperial College, London, UK
Forsch Komplementmed 13:174-83. 2006..Of these, Weak Quantum Theory (WQT) and Patient- Practitioner-Remedy (PPR) entanglement are developing into mathematically- based models of homeopathy...
- Homeopathy and the new fundamentalism: a critique of the criticsLionel R Milgrom
The Homeopathy Research Institute, London, United Kingdom
J Altern Complement Med 14:589-94. 2008..This may have consequences in the future for how practitioners, researchers, and patients of homeopathy/complementary and alternative medicine engage and negotiate with primary health care systems...
- Is using Nazi research to condemn homeopathy ethical or scientific?Lionel R Milgrom
Br J Clin Pharmacol 66:156-7; author reply 157-8. 2008